How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
To amend title XVIII of the Social Security Act to limit the coinsurance amount for certain services furnished in an ambulatory surgical center.
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
Artificial Intelligence and Machine Learning regulation and Medicare payment; Medicare Coverage of Innovative Medical Device; Medicare Physician Payment; Medicare Ambulatory Surgery Center and Hospital Outpatient Payment; Co-Pay Cap - H.R. 3006; S. 1776;
Medicare Beneficiary Co-Pay Fairness Act
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2026 · third_quarter · Q3
Trade Issues/Policy
Tax Issues;
EPA Regulations of Ethylene Oxide Sterilization of Medical Devices; EPA Regulations of PFAS
Source: Senate LDA
Artificial Intelligence and Machine Learning regulation and Medicare payment; Medicare Coverage of Innovative Medical Device; Medicare Physician Payment; Medicare Ambulatory Surgery Center and Hospital Outpatient Payment; Co-Pay Cap - H.R. 3006; S. 1776;
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
HR 1691; Medicare and Medicaid Treatment (EMMT) Act; Medicare Coverage of Innovative Medical Devices; Medicare Physician Payment; Medicare Ambulatory Surgery Center and Hospital Outpatient Payment; Disparities in Healthcare Coverage for Underserved Populations
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
Outpatient Surgical Quality and Access Act; H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act of 2023; Food and Drug Administration Regulatory Issues
Artificial Intelligence and Machine Learning regulation and Medicare payment; Medicare Coverage of Innovative Medical Device; Medicare Physician Payment; Medicare Ambulatory Surgery Center and Hospital Outpatient Payment;
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2026 · second_quarter · Q2
Tax Issues; Medical Device Tax repeal
Artificial Intelligence and Machine Learning regulation and Medicare payment; Medicare Coverage of Innovative Medical Device; Medicare Physician Payment; Medicare Ambulatory Surgery Center and Hospital Outpatient Payment; Co-Pay Cap - H.R. 3006; S. 1776;
Trade Issues/Policy
EPA Regulations of Ethylene Oxide Sterilization of Medical Devices; EPA Regulations of PFAS
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2026 · first_quarter · Q1
Trade Issues/Policy, Tariffs
Artificial Intelligence and Machine Learning regulation and Medicare payment; Medicare Coverage of Innovative Medical Device; Medicare Physician Payment; Medicare Ambulatory Surgery Center and Hospital Outpatient Payment; Physician Fee Schedule
Tax Issues; Enhanced ACA Tax Credit
EPA Regulations of Ethylene Oxide Sterilization of Medical Devices; EPA Regulations of PFAS
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2025 · fourth_quarter · Q4
Artificial Intelligence and Machine Learning regulation and Medicare payment; Medicare Coverage of Innovative Medical Device; Medicare Physician Payment; Medicare Ambulatory Surgery Center and Hospital Outpatient Payment; Physician Fee Schedule
Trade Issues/Policy, Tariffs
Tax Issues; Enhanced ACA Tax Credit
EPA Regulations of Ethylene Oxide Sterilization of Medical Devices; EPA Regulations of PFAS
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2025 · third_quarter · Q3
Artificial Intelligence and Machine Learning regulation and Medicare payment; Medicare Coverage of Innovative Medical Device; Medicare Physician Payment; Medicare Ambulatory Surgery Center and Hospital Outpatient Payment
Trade Issues/Policy
Tax Issues; ACA Tax Credit
EPA Regulations of Ethylene Oxide Sterilization of Medical Devices; EPA Regulations of PFAS
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2025 · second_quarter · Q2
Artificial Intelligence and Machine Learning regulation and Medicare payment; Medicare Coverage of Innovative Medical Device; Medicare Physician Payment; Medicare Ambulatory Surgery Center and Hospital Outpatient Payment
Trade Issues/Policy
Tax Issues
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2025 · first_quarter · Q1
Artificial Intelligence and Machine Learning regulation and Medicare payment; Medicare Coverage of Innovative Medical Devices; Medicare Physician Payment; Medicare Ambulatory Surgery Center and Hospital Outpatient Payment; Equality in Medicaid and Medicare Treatment Act
Trade Issues
Tax Issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2024 · fourth_quarter · Q4
Trade related policy;
Medicare Coverage of Innovative Medical Devices; Medicare Physician Payment; Medicare Ambulatory Surgery Center and Hospital Outpatient Payment; Artificial Intelligence and Machine Learning regulation and Medicare payment; Equality in Medicaid and Medicare Treatment Act
Tax Issues;
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2024 · third_quarter · Q3
Medicare Coverage of Innovative Medical Devices; Medicare Physician Payment; Medicare Ambulatory Surgery Center and Hospital Outpatient Payment; Artificial Intelligence and Machine Learning regulation and Medicare payment
Tax Issues; R&D tax policy
Artificial Intelligence and Machine Learning regulation and Medicare payment
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2024 · second_quarter · Q2
Trade related policy;
John Lewis Equality in Medicare and Medicaid Treatment Act of 2023; Medicare Coverage of Innovative Medical Devices; Medicare Physician Payment; Medicare Ambulatory Surgery Center and Hospital Outpatient Payment; Artificial Intelligence and Machine Learning regulation and Medicare payment
Tax Issues; R&D tax policy
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2024 · first_quarter · Q1
Trade related policy;
Tax Issues; R&D tax policy
Artificial Intelligence and Machine Learning regulation and Medicare payment
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2023 · fourth_quarter · Q4
Trade related policy;
Disparities in Healthcare Coverage for Underserved Populations; EPA Regulations of Ethylene Oxide Sterilization of Medical Devices
HR 1691; Medicare and Medicaid Treatment (EMMT) Act; Medicare Coverage of Innovative Medical Devices; Medicare Physician Payment; Medicare Ambulatory Surgery Center and Hospital Outpatient Payment; Disparities in Healthcare Coverage for Underserved Populations
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2023 · third_quarter · Q3
Trade Issues
Data Privacy; Cybersecurity
Equality in Medicaid and Medicare Treatment Act; Medicare and Medicaid Treatment (EMMT) Act; Medicare Physician Payment; Medicare Ambulatory Surgery Center and Hospital Outpatient Payment
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2023 · second_quarter · Q2
Tax Issues
Data Privacy; Cybersecurity
Medicare Physician Payment; Medicare Ambulatory Surgery Center and Hospital Outpatient Payment;Equality in Medicaid and Medicare Treatment Act
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2023 · first_quarter · Q1
Data Privacy; Cybersecurity
Food and Drug Administration Regulatory Issues
Medicare Physician Payment; Medicare Ambulatory Surgery Center and Hospital Outpatient Payment
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2022 · fourth_quarter · Q4
Data security; Medical Device User Fee Authorization; Cybersecurity
Shortage reporting; Predetermined Change Control Plans; Emerging Signals, Food and Drug Administration Regulatory Issues
Medicare Physician Payment; Medicare Ambulatory Surgery Center and Hospital Outpatient Payment
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2022 · third_quarter · Q3
Data security; Medical Device User Fee Authorization
Equality in Medicare and Medicaid Treatment Act; Medicare Physician Payment; ASC/OPPS Medicare Payment
Indiana workforce and transportation issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2022 · second_quarter · 2A
Data security
MDUFA V, shortage reporting, FDARA bill, PREVENT Act, Outpatient Surgery Quality and Access Act, oEquality in Medicare and Medicaid Treatment Act, Medical Device User Fee Authorization
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2022 · second_quarter · Q2
MDUFA V, shortage reporting, FDARA bill, PREVENT Act, Outpatient Surgery Quality and Access Act, oEquality in Medicare and Medicaid Treatment Act, Medical Device User Fee Authorization
Data security
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EPA Regulations of Ethylene Oxide Sterilization of Medical Devices; EPA Regulations of PFAS
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Artificial Intelligence and Machine Learning regulation and Medicare payment
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Trade related policy;
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Artificial Intelligence and Machine Learning regulation and Medicare payment
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
John Lewis Equality in Medicare and Medicaid Treatment Act of 2023; Medicare Coverage of Innovative Medical Devices; Medicare Physician Payment; Medicare Ambulatory Surgery Center and Hospital Outpatient Payment
EPA Regulations of Ethylene Oxide Sterilization of Medical Devices
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Tax Issues; R&D tax policy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Outpatient Surgical Quality and Access Act; H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act of 2023; Food and Drug Administration Regulatory Issues
Tax Issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Trade Issues
Food and Drug Administration Regulatory Issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Trade Issues
Tax Issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE